The Canadian Centre for Aging & Brain Health innovation is a solution accelerator focused on driving innovation in the aging and brain health sector. Established in 2015 through funding of $124 million (CAD), it is the result of the largest investment in brain health and aging in Canadian history, and one of the largest investments of its kind in the world.
CC-ABHI is a unique collaboration of health care, science, industry, not-for-profit and government partners whose aim is to help improve quality of life for the world’s aging population, allowing older adults to age safely in the setting of their choice while maintaining their cognitive, emotional, and physical well-being.
CC-ABHI facilitates collaborations among innovators, healthcare providers, private sector partners, government and consumers. Through its funding programs, CC-ABHI helps global innovators gain access to key user groups in order to test, develop, validate and accelerate their solutions in the field of aging and brain health.
CC-ABHI is spearheaded by Baycrest Health Sciences, a global leader in aging and brain health and home to one of the world’s top research institutes in cognitive neuroscience, with more than 98-years of experience in improving the well-being of the aging population. CC-ABHI builds on Baycrest’s much sought-after expertise and exemplary care experience.
CC-ABHI has received funding from the Government of Canada through the Public Health Agency of Canada, the Government of Ontario through the Ministry of Research, Innovation and Science, and the Baycrest Foundation.
To accelerate: development, validation, commercialization, dissemination and adoption of innovative products, services and best practices to support brain health and aging.
A world in which people can age in the setting of their choice, maintaining their cognitive, emotional and physical well-being as well as their independence for as long as possible.